Results 121 to 130 of about 31,245 (262)
Challenges in Implementing European Regulation on Water Reuse for Sustainable Agriculture
ABSTRACT The Regulation (EU) 2020/741 on minimum requirements for water reuse is a key policy for sustainable water management under growing water scarcity in Europe. This paper examines expert perspectives on the challenges involved in implementing EU regulation for water reuse in agriculture, aiming to broaden existing research, which is largely ...
Patricia Allgaier +2 more
wiley +1 more source
Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease Therapies. [PDF]
Blandy O +5 more
europepmc +1 more source
Learning Networks Drive Environmental Innovation: Evidence From Fourth‐Stage Purification Diffusion
ABSTRACT Contaminants of emerging concern, including pharmaceuticals and industrial chemicals, threaten water quality globally. In the European Union (EU), until the adoption of the revised Urban Wastewater Treatment Directive in 2024, a regulatory gap had left the member states and the municipalities in them without binding removal standards ...
Simon Bulian +3 more
wiley +1 more source
Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention. [PDF]
Guerzoni S +6 more
europepmc +1 more source
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
Consumer preferences for the development of new emulsion products based on vegetable and animal fats. [PDF]
Kowalska M +5 more
europepmc +1 more source
This review highlights non‐thermal extraction technologies for seaweed proteins, emphasizing their mechanisms, impacts on protein structure and functionality, and sustainability potential. Key limitations related to species dependence, extract complexity, and scale‐up are discussed to guide future industrial and biorefinery applications.
Rahat Mahmud +3 more
wiley +1 more source
Association of 340B entity eligibility with changes in hospital financial performance. [PDF]
Masia N +3 more
europepmc +1 more source
Pharmaceutical Pricing and R&D as a Global Public Good
ABSTRACT This paper examines the international variation in the prices of branded pharmaceuticals. We consider short‐run profits, or quasi‐rents, as representing each country's contribution toward the global public good of therapeutic information embodied in new pharmaceuticals.
H. E. Frech III +3 more
wiley +1 more source
Health-economic challenges for new Alzheimer's disease treatments. [PDF]
Fu J +30 more
europepmc +1 more source

